Tony Jones

Chief Executive Officer at One Nucleus

Tony has led One Nucleus, the not-for-profit life science membership group headquartered in Cambridge, UK since 2017. That period has seen the membership base grow and the activities to support innovation evolve to now include the dissemination of learning & development, purchasing, sustainability and laboratory development good practice. These activities in addition to the peer-to-peer networking and partnering opportunities by an array of events and conferences.

After completing a PhD in Biochemistry (1992) from the University of Southampton UK, Tony undertook several years of post-doctoral research in the oncology field, primarily with the Imperial Cancer Research Fund (now CRUK). In 1997, he moved into Technology Transfer with the Medical Research Council and later (1998) University College London, at the Wolfson Institute for Biomedical Research. In November 2003, Tony took up the post of Director of Biotechnology & Healthcare at London First, managing the London Biotechnology Network and promotion of London’s excellence in healthcare research and delivery. In May 2010 he took London Biotechnology Network into the merger with ERBI, creating One Nucleus.